Liberty Global (NASDAQ:LBTYA) reported quarterly sales of $1.75 billion which beat the analyst consensus estimate of $1.72 billion by 1.51 percent. This is a 8.15 percent decrease over sales of $1.90 billion the same period last year.
HDL Therapeutics Inc Plans To Become Publicly Traded Via A Business Combination With $225M Swiftmerge With Goal To Transform Cardiovascular Disease Treatment
IVCP Swiftmerge Acquisition Corp ("Swiftmerge"), a $225 million innovative healthcare investment corporation and a special purpose acquisition company, announced today the signing of a
